Glucocorticoid-Induced Adrenal Insufficiency in Sarcoidosis Patients with Long-term Glucocorticoid Therapy

Roman Düvel; Vanessa Marggraf; Carmen Pizarro; Leonie Biener; Wiebke Fenske; Charlotte Fries; Georg Nickenig; Christian Grohé; Dirk Skowasch

doi:10.1055/a-2510-9851

Pneumologie, Table of Contents

Pneumologie 2025; 79(03): 202-205
DOI: 10.1055/a-2510-9851

Letter to the Editor

Glucocorticoid-Induced Adrenal Insufficiency in Sarcoidosis Patients with Long-term Glucocorticoid Therapy

Roman Düvel

¹Herzzentrum des Universitätsklinikums Bonn, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany

,

Vanessa Marggraf

²Internal Medicine, Hausarztzentrum Rheinbach, Rheinbach, Germany

,

Carmen Pizarro

¹Herzzentrum des Universitätsklinikums Bonn, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany

,

Leonie Biener

¹Herzzentrum des Universitätsklinikums Bonn, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany

,

Wiebke Fenske

³Department of Internal Medicine I – General Internal Medicine, Endocrinology and Diabetology, Gastroenterology and Hepatology, BG University Hospital Bergmannsheil, Bochum, Germany

,

Charlotte Fries

³Department of Internal Medicine I – General Internal Medicine, Endocrinology and Diabetology, Gastroenterology and Hepatology, BG University Hospital Bergmannsheil, Bochum, Germany

,

Georg Nickenig

¹Herzzentrum des Universitätsklinikums Bonn, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany

,

Christian Grohé

⁴Klinik für Pneumologie Evangelische Lungenklinik Berlin, Berlin, Germany

,

Dirk Skowasch

¹Herzzentrum des Universitätsklinikums Bonn, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Sève P, Pacheco Y, Durupt F. et al. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells 2021; 10: 766
2 Baughman RP, Valeyre D, Korsten P. et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021; 58: 2004079
3 Skowasch D, Bonella F, Buschulte K. et al. Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) [Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)]. Pneumologie 2024; 78: 151-166
4 Tana C, Drent M, Nunes H. et al. Comorbidities of sarcoidosis. Ann Med 2022; 54: 1014-1035
5 Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40: 255-263
6 Beuschlein F, Else T, Bancos I. et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Endocrinol 2024; 190: G25-G51
7 Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ 2021; 374: n1380 Erratum in: BMJ 2021; 374: n1936. doi:10.1136/bmj.n1936
8 Kienitz T, Meyer G. Neue Aspekte der Glukokortikoidsubstitution bei Nebennierenrindeninsuffizienz. Internist 2022; 63: 12-17
9 Menzies-Gow A, Gurnell M, Heaney LG. et al. Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. Lancet Respir Med 2022; 10: 47-58 Erratum in: Lancet Respir Med 2021; 9: e114
10 Farin E, Heyduck K, Frye BC. et al. Translation and psychometric properties of the King’s Sarcoidosis Questionnaire (KSQ) in German language. Health Qual Life Outcomes 2019; 17 Article number 62
11 Øksnes M, Bensing S, Hulting AL. et al. Quality of life in European patients with Addisonʼs disease: validity of the disease-specific questionnaire AddiQoL. J Clin Endocrinol Metab 2012; 97: 568-576
12 Biener L, Kruse J, Tuleta I. et al. Association of proangiogenic and profibrotic serum markers with lung function and quality of life in sarcoidosis. PLoS One 2021; 16: e0247197